Home > Healthcare > Drug Device Combination > Drug Filled Devices > Ureteral Stents Market

Ureteral Stents Market Trends

Report ID: GMI8522
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Ureteral Stents Market Trends

Advancements in healthcare technology have played a pivotal role in shaping and improving various medical interventions, and this progress has significantly contributed to the growth and development of ureteral stents. These technological innovations have enhanced the design, placement procedures, and overall efficacy of ureteral stents, making them more efficient tools in the management of urological disorders.

The development of biomaterials and coatings has been a key driver in improving the safety and effectiveness of ureteral stents. Innovations in materials science have led to the use of substances that minimize irritation, inflammation, and encrustation, thereby enhancing patient comfort and reducing the need for premature stent removal. Coatings with antimicrobial properties also help prevent urinary tract infections associated with stent usage, further promoting their long-term viability.
Moreover, 3D printing technology has enabled the production of personalized and anatomically accurate ureteral stents. This customization allows healthcare professionals to tailor stents to fit the unique anatomy of each patient, optimizing the therapeutic outcome. Customized stents enhance comfort, reduce complications, and improve overall patient satisfaction, marking a significant leap forward in the application of healthcare technology in urology.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Ureteral stents industry was worth USD 470.6 million in revenue in 2023 and is expected to expand at 6% CAGR from 2024-2032 attributed to the increasing prevalence of urological disorders coupled with the rising need for minimally invasive procedures.

The double pigtail segment accounted for USD 177.8 million in revenue in 2023 and is estimated to record substantial growth through 2032 owing to the unique design innovation of ureteral stents, contributing to their widespread use and acceptance in urological interventions.

North America ureteral stents market generated USD 190.6 million in revenue in 2023 and is set to exhibit robust growth during 2024-2032 driven by the significant prevalence of urological disorders, including conditions, such as kidney stones, UTIs, and bladder-related issues.

Some of the major companies operating in the ureteral stents industry are Allium Medical, B.Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Coloplast, Cook Medical, Olympus Corporation, Pnn Medical A/S, Teleflex Inc., and Uromed.